biopharmaceutical manufacturing
In North Carolina, FUJIFILM Diosynth Investing $1.2B To Expand Biopharma Manufacturing
Building on the company's investment of $2 billion in 2021, the Wake County, NC plant is set to be the largest end-to-end biopharma manufacturing facility in North America.
National Resilience To Invest $225M In Cincinnati Site
National Resilience, a technology-focused biomanufacturing company, will expand clinical and commercial drug product manufacturing.
SK bioscience Plans $261M Vaccine, Biopharm Center
Created to fight new infectious diseases, the Songdo Global Research & Process Development Center will house vaccine and biopharmaceutical activities ranging from basic research to commercial manufacturing.